Therapeutic combination for treatment of Alzheimers disease

Details for Australian Patent Application No. 2005232447 (hide)

Owner Warner-Lambert Company LLC

Inventors Larson, Gregg H.

Agent Spruson & Ferguson

Pub. Number AU-A-2005232447

PCT Pub. Number WO2005/099823

Priority 60/562,141 14.04.04 US

Filing date 4 April 2005

Wipo publication date 27 October 2005

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/099823 Priority application(s): WO2005/099823

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232465-Laser treatment

2005232446-A connector for a fluid line in an extracorporeal circuit